Cargando…
What inference for two-stage phase II trials?
BACKGROUND: Simon’s two-stage designs are widely used for cancer phase II trials. These methods rely on statistical testing and thus allow controlling the type I and II error rates, while accounting for the interim analysis. Estimation after such trials is however not straightforward, and several di...
Autores principales: | Porcher, Raphaël, Desseaux, Kristell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445829/ https://www.ncbi.nlm.nih.gov/pubmed/22867439 http://dx.doi.org/10.1186/1471-2288-12-117 |
Ejemplares similares
-
Correlation between clinical severity and different non-invasive measurements of carbon monoxide concentration: A population study
por: Hullin, Thomas, et al.
Publicado: (2017) -
Statistical inference for extended or shortened phase II studies based on Simon’s two-stage designs
por: Zhao, Junjun, et al.
Publicado: (2015) -
Minimax and admissible adaptive two-stage designs in phase II clinical trials
por: Shan, Guogen, et al.
Publicado: (2016) -
Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
por: Qin, Fei, et al.
Publicado: (2020) -
Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
por: Wason, James M. S., et al.
Publicado: (2012)